MCC
AUPH icon

Money Concepts Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Money Concepts Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,725
Closed -$7.45K – 630
2022
Q4 		$7.45K Buy
+1,725
New +$10K ﹤0.01% 2166
2022
Q2 		– Sell
-75
Closed -$1K – 1513
2022
Q1 		$1K Buy
+75
New +$1.16K ﹤0.01% 2531

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Money Concepts Capital's AUPH Position: Q1 2023 in Review

Money Concepts Capital sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2023, closing a stake of 1,725 shares — an estimated $7.45K sold.

Money Concepts Capital first reported a position in AUPH in Q1 2022 and held it in 2 quarters. The position peaked at $7.45K in Q4 2022. 186 funds tracked by Wall St. Rank hold AUPH as of Q1 2023.

  • Money Concepts Capital reported no remaining Aurinia Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 1,725 Aurinia Pharmaceuticals shares in Q1 2023, an estimated $7.45K.
  • Money Concepts Capital first reported a position in Aurinia Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's Aurinia Pharmaceuticals position peaked at $7.45K in Q4 2022.
  • 186 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.